Akebia Therapeutics, Inc.
AKBA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $540 | $247 | $6,112 | -$22,804 |
| Dep. & Amort. | $318 | $316 | $314 | $13,543 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,221 | $0 | $2,187 | $0 |
| Change in WC | $19,227 | $5,100 | -$29,726 | -$3,231 |
| Other Non-Cash | $4,799 | $16,682 | $7,526 | $8,026 |
| Operating Cash Flow | $28,105 | $22,345 | -$13,587 | -$4,466 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$77 | -$126 | -$18 | -$2 |
| Net Acquisitions | $0 | $0 | $172 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$77 | -$126 | $154 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $9,538 | -$1,271 |
| Stock Issued | $152 | $1,720 | $64,985 | $22,324 |
| Stock Repurch. | $0 | $0 | -$63 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $961 | $0 | $482 | $1,272 |
| Financing Cash Flow | $1,113 | $1,720 | $74,942 | $22,325 |
| Forex Effect | $0 | -$5 | $0 | -$6 |
| Net Chg. in Cash | $29,141 | $23,934 | $61,509 | $17,851 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $138,998 | $113,374 | $53,550 | $34,019 |
| End Cash | $168,139 | $137,308 | $115,059 | $51,870 |
| Free Cash Flow | $28,028 | $22,219 | -$13,605 | -$4,468 |